What is Pelthos Therapeutics Inc.'s Market Cap?

Pelthos Therapeutics Inc.'s Market Cap is $94.0M, based on as-reported figures from SEC (XBRL) filings.

What is Pelthos Therapeutics Inc.'s Enterprise Value?

Pelthos Therapeutics Inc.'s Enterprise Value is $69.8M, based on as-reported figures from SEC (XBRL) filings.

What is Pelthos Therapeutics Inc.'s Price / Sales?

Pelthos Therapeutics Inc.'s Price / Sales is 2.2×, based on as-reported figures from SEC (XBRL) filings.

What is Pelthos Therapeutics Inc.'s EV / Revenue?

Pelthos Therapeutics Inc.'s EV / Revenue is 1.6×, based on as-reported figures from SEC (XBRL) filings.

What is Pelthos Therapeutics Inc.'s EV / EBITDA?

Pelthos Therapeutics Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Pelthos Therapeutics Inc.'s Revenue (TTM)?

Pelthos Therapeutics Inc.'s Revenue (TTM) is $43.3M, based on as-reported figures from SEC (XBRL) filings.

What is Pelthos Therapeutics Inc.'s Net Income (TTM)?

Pelthos Therapeutics Inc.'s Net Income (TTM) is -$86.4M, based on as-reported figures from SEC (XBRL) filings.

What is Pelthos Therapeutics Inc.'s EBITDA?

Pelthos Therapeutics Inc.'s EBITDA is -$52.7M, based on as-reported figures from SEC (XBRL) filings.

What is Pelthos Therapeutics Inc.'s Diluted EPS (TTM)?

Pelthos Therapeutics Inc.'s Diluted EPS (TTM) is -22.57, based on as-reported figures from SEC (XBRL) filings.

What is Pelthos Therapeutics Inc.'s EBITDA Margin?

Pelthos Therapeutics Inc.'s EBITDA Margin is -121.6%, based on as-reported figures from SEC (XBRL) filings.

Pelthos Therapeutics Inc. (PTHS) Financial Statements

Pelthos Therapeutics Inc.

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG01C9YP6S7

XASE · usd

24.55▲ 0.20 (0.82%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close24.35

Day's Range23.26 – 24.61

52-Week Range18.19 – 37.50

Volume40.7K

Avg Volume75.6K

Share Statistics

Shares Outstanding

Employees92

ExchangeXASE

Listed2024-02-16

Share count as of August 10, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Pelthos Therapeutics Inc. (PTHS)

What is Pelthos Therapeutics Inc.'s Market Cap?: Pelthos Therapeutics Inc.'s Market Cap is $94.0M, based on as-reported figures from SEC (XBRL) filings.
What is Pelthos Therapeutics Inc.'s Enterprise Value?: Pelthos Therapeutics Inc.'s Enterprise Value is $69.8M, based on as-reported figures from SEC (XBRL) filings.
What is Pelthos Therapeutics Inc.'s Price / Sales?: Pelthos Therapeutics Inc.'s Price / Sales is 2.2×, based on as-reported figures from SEC (XBRL) filings.
What is Pelthos Therapeutics Inc.'s EV / Revenue?: Pelthos Therapeutics Inc.'s EV / Revenue is 1.6×, based on as-reported figures from SEC (XBRL) filings.
What is Pelthos Therapeutics Inc.'s EV / EBITDA?: Pelthos Therapeutics Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Pelthos Therapeutics Inc.'s Revenue (TTM)?: Pelthos Therapeutics Inc.'s Revenue (TTM) is $43.3M, based on as-reported figures from SEC (XBRL) filings.
What is Pelthos Therapeutics Inc.'s Net Income (TTM)?: Pelthos Therapeutics Inc.'s Net Income (TTM) is -$86.4M, based on as-reported figures from SEC (XBRL) filings.
What is Pelthos Therapeutics Inc.'s EBITDA?: Pelthos Therapeutics Inc.'s EBITDA is -$52.7M, based on as-reported figures from SEC (XBRL) filings.
What is Pelthos Therapeutics Inc.'s Diluted EPS (TTM)?: Pelthos Therapeutics Inc.'s Diluted EPS (TTM) is -22.57, based on as-reported figures from SEC (XBRL) filings.
What is Pelthos Therapeutics Inc.'s EBITDA Margin?: Pelthos Therapeutics Inc.'s EBITDA Margin is -121.6%, based on as-reported figures from SEC (XBRL) filings.